$15.72
0.22[1.42%]
Last update: 3:41PM Get Real Time Here
Immunome
(NASDAQ:IMNM)Latest News for Immunome Stock (NASDAQ:IMNM)
Immunome Stock (NASDAQ: IMNM)
Categories: All
Monday, May 13, 2024
Tuesday, April 30, 2024
Monday, April 15, 2024
Wednesday, April 03, 2024
- Immunome Files For Shelf Of Up To 2.2M Shares Of Common Stock By Selling StockholderBenzinga Newsdesk - Apr 3, 2024, 4:51PM
- Immunome Inc Filed Prospectus Relates To Proposed Resale From Time To Time By Selling Stockholder Of 2.3M Shares, Or Shares, Of Common StockBenzinga Newsdesk - Apr 3, 2024, 4:49PM
Monday, April 01, 2024
Thursday, March 28, 2024
Friday, March 22, 2024
Monday, March 18, 2024
Wednesday, February 28, 2024
Thursday, February 22, 2024
Tuesday, February 20, 2024
Wednesday, February 14, 2024
Tuesday, February 13, 2024
Tuesday, February 06, 2024
- Immunome shares are trading higher after the company announced that it entered into a definitive asset purchase agreement with Ayala Pharmaceuticals to acquire AL102 and AL101 drug candidates.Benzinga Newsdesk - Feb 6, 2024, 3:38PM
- 12 Health Care Stocks Moving In Tuesday's Intraday SessionBenzinga Insights - Feb 6, 2024, 12:31PM
- Immunome To Acquire AL102 And AL101 Drug Candidates From Ayala; Immunome Will Pay $20M In Cash And $30M In Immunome Common Stock And Up To $37.5M In MilestonesBenzinga Newsdesk - Feb 6, 2024, 8:06AM
Tuesday, January 23, 2024
Monday, January 08, 2024
Tuesday, December 26, 2023
- Immunome shares are trading higher after the company announced that it entered into a definitive asset purchase agreement with Atreca.Benzinga Newsdesk - Dec 26, 2023, 3:42PM
- Immunome To Acquire Antibody-Related Assets And Materials From Atreca; Under The Terms Of The Asset Purchase Agreement, Immunome Would Pay Atreca A $5.5M Upfront Payment And Up To $7M In Clinical Development MilestonesHappy Mohamed - Dec 26, 2023, 8:31AM
Tuesday, December 19, 2023
Friday, November 10, 2023
Thursday, November 09, 2023
Wednesday, November 01, 2023
- Chief Medical Officer at Immunome Acquires Company Stock Options Worth 400,000 SharesBenzinga Insights - Nov 1, 2023, 11:01AM
- Immunome Board Member Awarded $355K Worth of Stock OptionsBenzinga Insights - Nov 1, 2023, 11:00AM
- Immunome Director Awarded $355K Worth of Stock OptionsBenzinga Insights - Nov 1, 2023, 11:00AM
Thursday, October 05, 2023
Wednesday, August 09, 2023
Thursday, June 29, 2023
- Nasdaq Moves Lower; Acuity Brands Earnings Top EstimatesLisa Levin - Jun 29, 2023, 2:32PM
- Why Franklin Covey Shares Are Trading Higher By 25%? Here Are Other Stocks Moving In Thursday's Mid-Day SessionLisa Levin - Jun 29, 2023, 1:52PM
- 12 Health Care Stocks Moving In Thursday's Intraday SessionBenzinga Insights - Jun 29, 2023, 1:37PM
- Immunome shares are trading higher after the company and Morphimmune announced a definitive merger agreement and simultaneous private placement investment of $125 million to develop targeted cancer therapies.Benzinga Newsdesk - Jun 29, 2023, 11:39AM
- Why Are Immunome Shares Trading Higher TodayVandana Singh - Jun 29, 2023, 10:48AM
- Dow Rises Over 100 Points; US GDP Grows 2% In Q1Lisa Levin - Jun 29, 2023, 10:10AM
- 12 Health Care Stocks Moving In Thursday's Pre-Market SessionBenzinga Insights - Jun 29, 2023, 9:12AM
- Immunome And Morphimmune Announce Definitive Merger Agreement And Simultaneous Private Placement Investment Of $125M To Develop Targeted Cancer TherapiesBenzinga Newsdesk - Jun 29, 2023, 9:03AM
Wednesday, June 28, 2023
Tuesday, May 23, 2023
Friday, May 05, 2023
Monday, March 20, 2023
Friday, March 17, 2023
Friday, January 06, 2023
- Why Spruce Biosciences Shares Are Trading Higher By 100%? Here Are Other Stocks Moving In Friday's Mid-Day SessionLisa Levin - Jan 6, 2023, 1:16PM
- Immunome Stock Jumps On Discovery Pact With AbbVieVandana Singh - Jan 6, 2023, 10:35AM
- Dow Rises Over 300 Points; US Adds 223,000 Jobs In DecemberLisa Levin - Jan 6, 2023, 10:27AM
- Immunome Shares Resume Trade Following Circuit Breaker Halt, Stock Now Up 14.4%Benzinga Newsdesk - Jan 6, 2023, 9:44AM
- Immunome Shares Halted On Circuit Breaker To The Downside, Stock Now Up 9.34%Benzinga Newsdesk - Jan 6, 2023, 9:39AM
- Immunome shares are trading higher after the company and AbbVie announced a strategic collaboration to discover multiple novel oncology targets. Immunome will receive a $30 million upfront payment with the potential for milestones and royalties.Benzinga Newsdesk - Jan 6, 2023, 8:50AM